Defining the Role of MitraClip Therapy for Mitral Valve Regurgitation | Zendy

Faisal H. Cheema | Zendy; Pranav Loyalka | Zendy; Keshava Rajagopal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Defining the Role of MitraClip Therapy for Mitral Valve Regurgitation

Author(s) -

Faisal H. Cheema,

Pranav Loyalka,

Keshava Rajagopal

Publication year - 2020

Publication title -

texas heart institute journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.373

H-Index - 53

eISSN - 1526-6702

pISSN - 0730-2347

DOI - 10.14503/thij-19-7082

Subject(s) - mitraclip , medicine , cardiology , mitral regurgitation , heart failure , ventricle , chordae tendineae , mitral valve , mitral valve repair , myocardial infarction

M itral valve regurgitation (MR) often occurs in patients who are poor candidates for conventional cardiac surgery, particularly in those with advanced heart failure (HF) who are at increased risk of perioperative surgical complications. Catheter-based therapies for mitral valve (MV) repair, such as the MitraClip (Abbott), have been developed. We discuss a conceptual framework for classifying MR by etiology and morphology; techniques, risks, and benefits of surgical and MitraClip repair; and indications for MitraClip therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research